{
    "2020-10-31": [
        [
            {
                "time": "",
                "original_text": "基金三季报收官：隆基股份受宠 两大医药龙头被减持 减持股份数量",
                "features": {
                    "keywords": [
                        "基金",
                        "三季报",
                        "隆基股份",
                        "医药龙头",
                        "减持"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "基金三季报收官：隆基股份受宠 医药龙头分化",
                "features": {
                    "keywords": [
                        "基金",
                        "三季报",
                        "隆基股份",
                        "医药龙头",
                        "分化"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源",
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}